Assessment of Tocilizumab in the Treatment of Cancer Cachexia Reply

被引：3

作者：

Ando, Katsutoshi ^{[1
]}

Takahashi, Fumiyuki ^{[1
]}

Takahashi, Kazuhisa ^{[1
]}

机构：

[1] Juntendo Univ, Grad Sch Med, Tokyo, Japan

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 23期

关键词：

INTERLEUKIN-6;

D O I：

10.1200/JCO.2013.50.4324

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

引用

收藏

页码：2971 / 2971

页数：1

相关论文

共 8 条

[1]

Possible Role for Tocilizumab, an Anti-Interleukin-6 Receptor Antibody, in Treating Cancer Cachexia [J].

Ando, Katsutoshi ;

Takahashi, Fumiyuki ;

Motojima, Shinji ;

Nakashima, Kei ;

Kaneko, Norihiro ;

Hoshi, Kazuei ;

Takahashi, Kazuhisa .

JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06) :E69-E72

[2]

Assessment of Tocilizumab in the Treatment of Cancer Cachexia [J].

Berti, Alvise ;

Boccalatte, Francesco ;

Sabbadini, Maria Grazia ;

Dagna, Lorenzo .

JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (23) :2970-2970

[3]

Roles of interleukin-6 in activation of STAT proteins and recruitment of neutrophils during Escherichia coli pneumonia [J].

Jones, MR ;

Quinton, LJ ;

Simms, BT ;

Lupa, MM ;

Kogan, MS ;

Mizgerd, JP .

JOURNAL OF INFECTIOUS DISEASES, 2006, 193 (03) :360-369

[4]

Blockade of Interleukin 6 Signaling Induces Marked Neutropenia in Patients with Rheumatoid Arthritis [J].

Nakamura, Ichiro ;

Omata, Yasunori ;

Naito, Masashi ;

Ito, Katsumi .

JOURNAL OF RHEUMATOLOGY, 2009, 36 (02) :459-460

[5]

Safety and Efficacy of Tocilizumab for the Treatment of Rheumatoid Arthritis [J].

Ogata, Atsushi ;

Hirano, Toru ;

Hishitani, Yoshihiro ;

Tanaka, Toshio .

CLINICAL MEDICINE INSIGHTS-ARTHRITIS AND MUSCULOSKELETAL DISORDERS, 2012, 5 :27-42

[6]

Smolen JS, 2008, ANALYSIS OF BASELINE

[7]

Tisdale Michael J, 2003, J Support Oncol, V1, P159

[8]

Biology of cachexia [J].

Tisdale, MJ .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (23) :1763-1773